Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred K Cheung

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
Diabetes Care|August 11, 2017
Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized TrialAdam P Bress, Jordan B King, Kathryn E Kreider, et al.
European Journal of Heart Failure|August 25, 2017
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitorsJaved Butler, Carine E Hamo, Gerasimos Filippatos, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2017
Effects of Intensive BP Control in CKDAlfred K Cheung, Mahboob Rahman, David M Reboussin, et al.
Plos One|April 23, 2021
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US VeteransCatherine G Derington, Jordana B Cohen, April F Mohanty, et al.
The New England Journal of Medicine|November 4, 2022
Empagliflozin in Patients with Chronic Kidney Disease, William G Herrington, Natalie Staplin, et al.
The New England Journal of Medicine|October 25, 2024
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease, William G Herrington, Natalie Staplin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trialsMark D Okusa, Bruce A Molitoris, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settingsBruce A Molitoris, Mark D Okusa, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodologyPaul M Palevsky, Bruce A Molitoris, Mark D Okusa, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
Diabetes Care|August 11, 2017
Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized TrialAdam P Bress, Jordan B King, Kathryn E Kreider, et al.
European Journal of Heart Failure|August 25, 2017
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitorsJaved Butler, Carine E Hamo, Gerasimos Filippatos, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2017
Effects of Intensive BP Control in CKDAlfred K Cheung, Mahboob Rahman, David M Reboussin, et al.
Plos One|April 23, 2021
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US VeteransCatherine G Derington, Jordana B Cohen, April F Mohanty, et al.
The New England Journal of Medicine|November 4, 2022
Empagliflozin in Patients with Chronic Kidney Disease, William G Herrington, Natalie Staplin, et al.
The New England Journal of Medicine|October 25, 2024
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease, William G Herrington, Natalie Staplin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trialsMark D Okusa, Bruce A Molitoris, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settingsBruce A Molitoris, Mark D Okusa, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodologyPaul M Palevsky, Bruce A Molitoris, Mark D Okusa, et al.
Pageof 27